Microbial Protein Market

Key data points: Market size in 2027 = $1.7 billion and 2035 = $4.9 billion, growth forecast = 14.1% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in microbial protein market to 2035 by protein type (algae protein, mycoprotein, bacterial protein, and yeast protein), application (food & beverages, supplements, animal feed, industrial, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World) Microbial Protein Market The future of the global microbial protein market looks promising with opportunities in the food & beverage, supplement, animal feed, and industrial markets. The global microbial protein market is expected to reach an estimated $4.9 billion by 2035 from $1.7 billion in 2027 with a CAGR of 14.1% from 2027 to 2035. The major drivers for this market are the increasing demand for sustainable protein sources, the rising awareness about plant-based diets, and the growing need for alternative protein sources. • Lucintel forecasts that, within the protein type category, mycoprotein is expected to witness the highest growth over the forecast period due to it has a texture similar to meat. • Within the application category, food & beverages is expected to witness the highest growth over the forecast period due to the increasing awareness of the need for sustainable protein sources. • In terms of regions, Europe is expected to witness the highest growth over the forecast period due to increasing preference by consumers for plant-based and sustainably-produced food. Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below. Emerging Trends in Microbial Protein Market Lucintel predicts the microbial protein market beyond 2025 will focus on commercial-scale production. Clearer regulations and decreasing carbon emissions in the food and animal feed markets will create interest in alternative protein sources. Lucintel expects positive market trends for precision and biomass fermentation. • Precision Fermentation: An increasing number of regulations for dairy proteins and enzymes has been noted in the United States and Europe for the 2025-2027 period. Several commercial production facilities of more than 100,000 liters are being planned. • Feed Applications: Microbial protein production, especially for use in aquaculture and pet foods, offers more near-term market opportunities due to higher volatility in fish and plant protein production and more stable and reliable sourcing compared to other protein sources. • Sustainability: The Good Food Institute reported in 2024 that more than $1 billion had been invested in companies using fermentation to produce food. The lowered environmental impact and required land and water usage, as compared to traditional protein production, creates a competitive advantage for fermentation-based protein production. • Automation: The fermentation industry is quickly advancing automation. By 2025, producers expect to use larger, AI-managed bioreactors requiring less human oversight, and to build more densely packed fermentation suites. As the industry continues to grow and automate, the cost of production will likely decrease. • Regional Supply Chain Diversification: To ensure stability, drug developers in Europe, North America and Asia are fermenting drugs in multiple locations as opposed to relying on a single source. New pilot and demonstration plants are helping finance this diversification. By 2030, supplying drugs through multiple locations will allow for faster and more reliable distribution. The cost per kilogram will be an important factor in competitiveness, and producing a consistent drug with an acceptable taste will require the industry to rapidly advance fermentation technologies. Feeding the market with fermented drugs is likely to occur before feeding the market with fermented food. Transparent contracts and combination of fermentation, manufacturing and distribution will most likely win the best business partnerships Recent Developments in the Microbial Protein Market The microbial protein market is transitioning from a pilot market to a commercial market. The next several years will be focused on improving the economics of fermentation and regulatory approval. In addition, microbial feed proteins and commercial partnerships to establish customer markets will be developed. Over this same period, Lucintel expects continuation of an investment strategy to fund research to expand and enhance microbial protein production systems. • Expanding Production: ENOUGH announced plans to construct a commercial plant in Scotland, which upon completion would produce 10,000 metric tons of mycoprotein per year. Other commercial plants will likely influence the microbial protein market in the next five to ten years. • Commercial Relationships: The microbial protein market will continue to evolve with additional commercial partnerships. One such partnership announced in March 2025, was between Solar Foods and Fazer, where Solin will be produced at Fazer’s food production facilities and integrated into food products. • New Products: Solar Foods, in partnership with other firms, announced the commercial production of foodstuffs containing Solin in 2025. • Regulatory Approvals: In 2025, several countries continued evaluating precision- and biomass-fermentation foods, with Singapore again approving these foods ahead of other countries. • Investment Discipline: Like in past years, 2025 showed limited alternative-protein financing. Companies focused on building small-scale facilities. As reported in the 2022 Alternative Protein Investor Survey, the primary factor influencing investor interest will be platform performance and unit economics, not the total amount of financing raised. Therefore, in the next few years, the platforms that demonstrate the best unit economics will be prioritized for funding and will be able to scale their operations. Narrowing The Focus: There is increased focus on the supply chain. Producing consistent, reliable feedstock and establishing customer contracts will be more valuable than expanding the product line. Integration of microbial protein into more conventional food products will reduce consumer acceptance challenges. The first movers in this space may be able to command a price premium; however, they will be more vulnerable to competitor pressures. Some of the companies in this space will be able to scale operations, while others will be perceived as overfunded, failing businesses. Strategic Growth Opportunities in the Microbial Protein Market Commercial trends suggest increased interest in alternative, lower-impact protein sources. Market penetration of alternative protein sources will increase in the 2024-2026 period due to growing concerns regarding food security, coupled with investment in protein fermentation and efforts by retail customers to reduce emissions in their supply chains. Lucintel has published its views on market opportunities for proteins derived from microbes for use in food, animal feed and supplements. Commercialization of such technologies has progressed beyond the pilot stage. • Alternative Meat: Myco- and other microbial proteins can enhance texture and protein content of alternative meat products. Quorn, a myco-protein meat alternative, has more than 2000 listings in the food service sector in the UK as of March 2025. Further, some end users may prefer alternative meat products that are less reliant on plant-based proteins. • Aquaculture and Pet Foods: Microalgae and other microbial proteins can provide essential amino acids and reduce the use of traditional fish meal in animal feeds. Microbial fermentation can improve feed digestibility and reduce the cost of feed ingredients. • Developments in Fermentation Technology: It can enable the large scale production of protein for use in sports nutrition, medical foods and nutritionally complete meals for the elderly. Everyday protein needs of certain athletes has been estimated to be as high as 2.2g/kg by the International Society of Sports Nutrition. In comparison to commodity proteins, specialized protein products for sports nutrition and medical foods can command a significant price premium. • 2025 Disrupted International Supply Chains: Investing in fermentation facilities in various regions will allow the industries mentioned above to be less reliant on international supply and trade disruptions. The European Union has invested over 1 billion euros in the fund to enhance food security through the Horizon Europe program. Similar investments in other regions will achieve the same goals. • There is A Growing Focus on The Use of Microorganisms: To produce proteins to replace the use of fossil fuels in the manufacture of chemicals, health and nutrition products, and fertilizers. The World Bank reported that the food system is responsible for 30 percent of all greenhouse gas emissions in 2020. Microbial proteins have a potential advantage over conventional proteins, if carbon accounting is used to evaluate their use. Unless a clear commercial need is satisfied, microbial proteins will have a hard time replacing conventional proteins. Within the scope of consumer protein requirements, microbial proteins have clearer commercial rationale to satisfy feed, nutrition and manufacturing requirements. Microbial Protein Market Drivers and Challenges The microbial protein market is propelled by the surge in the need for sustainability in sources of protein, innovative fermentation technologies, and regulation and frameworks. Challenges include cost and risk in product acceptance and approval. Lucintel considered the mentioned factors to be the crucial elements that will shape the market in the near term. The factors responsible for driving this market include : • Increasing Demand: There is growing interest in high protein, low impact foods. The alternative protein market also benefitted from the growing interest in flexitarian lifestyle in 2025. During the same period, several food processing companies announced the launch of alternative meat products. It is expected that this demand will also create a pathway for microbial protein products in meat and other alimentary alternatives as well as in pharmaceutical and animal feed products. • Advancing Technology: The use of continuous processing, artificial intelligence, and other recent innovations in separation and downstream processing have improved consistency and productivity in fermentation. In 2025, several companies announced the completion of their fermentation pilot plants of over 100,000 liter capacities. Further improvements in fermentation technologies will help in reducing the cost and improving the taste and texture of fermented protein products. Additionally, these innovations will help in the large-scale production of protein products customized to have specific functional and nutritional attributes. • Regulatory Support: Updated regulatory frameworks have strengthened investor confidence in the food innovation sector. In February 2025, regulators in multiple jurisdictions continued assessing alternative protein applications under existing food safety policies. Over the next 3-5 years, we expect regulators will continue improving frameworks to expedite the market entrance of novel and farm-grown ingredients. This will particularly benefit the microbial food ingredients sector by enabling international trade and building consumer trust. • Sustainability: Compared to traditional livestock, producing microbial protein can use more of the ecosystem (less land and water) and can help alleviate food and feed concerns by using agricultural by-products. Continuing in April 2025, various analyses assessed alternative-protein systems and traditional livestock systems to evaluate potential impacts, including greenhouse gas emissions and water use. This trend will help microbial protein products become more competitive and accessible in the food and beverage market. • Manufacturing: Continuous improvements in fermentation technologies (larger fermenters, process automation, and biorefineries) and supply chain innovations will help further lower costs and increase reliability and safety of supply. In May 2025, the focus of the microbial protein industry was on building larger scale fermentation facilities. Within the next few years, we expect similar changes that will make microbial protein more price competitive with traditional and value-added proteins. The challenges facing this market include: • Large Start-Up Costs: Commercial-scale microbial protein production includes a substantial amount of downstream and upstream processing equipment, fermentation equipment, and supporting infrastructure. Most alternative protein projects require investments in the tens of millions to hundreds of millions of dollars to build out a commercial production facility. Large start-up costs will condense market competition by preferencing large companies, increasing reliance on strategic alliances, and increasing the importance of a company’s financial backers for market expansion. • Public Acceptance: Consumer perception of fermentation-based food ingredients is less developed. Tradition and perception may lead consumers to believe that food produced from fermentation is artificial, and possibly unsafe. In June 2025, consumers in large, developing markets, especially Latin America and Asia, were least accepting of alternative protein sources. This market obstacle will require the alternative protein industry to focus on product differentiation through improved perception of food safety and sensory appeal • Sugar, Agricultural By-products, Minerals, Fuel, and Water Can Increase Production Costs: Regulations that impact biorefineries also vary from country to country. In August 2025, biorefinery developers were assessing various feedstocks and production locations to decrease price-variation risk. These situations will push companies to improve their processes and to use diverse, reputable supply sources. It will also increase the number of production facilities and create a competitive market. Rising consciousness towards sustainability has created a need for high-quality protein for animal nutrition. For the market to grow, similar advancements are necessary for other areas like production volume and process. While a positive business environment and regulatory clarity can speed up time-to-market for bioproteins, high costs and investors' risk aversion may hinder research. In the next 5 years, companies that create a competitive, safe, quality product and establish trust through reliable compliance and transparency will thrive and gain the most compositable positions in the market. List of Microbial Protein Market Companies Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies microbial protein market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the microbial protein market companies profiled in this report include- • Cyanotech Corporation • Corbion N.V. • ENOUGH • Naplasol BV • Roquette Frères S.A. • KnipBio Inc. • Algenol Biotech LLC • Alver World SA • Enifer • Zilor Microbial Protein Market by Segment The study includes a forecast for the global microbial protein market by protein type, application, and region. Microbial Protein Market by Protein Type [Value ($B) from 2019 to 2035]: • Algae Protein • Mycoprotein • Bacterial Protein • Yeast Protein Microbial Protein Market by Application [Value ($B) from 2019 to 2035]: • Food & Beverages • Supplements • Animal Feed • Industrial • Others Microbial Protein Market by Region [Value ($B) from 2019 to 2035]: • North America • Europe • Asia Pacific • The Rest of the World Country Wise Outlook for the Microbial Protein Market The microbial protein market is transitioning from small-scale productions to larger-scale, commercial productions. This transition has been funded by public and private entities. Food safety approvals provide a pathway for commercialization. Some predict that by 2027, the microbial protein market will increase based on the platforms that achieve acceptable economics. According to Lucintel, organizations will continue to invest in research and development to advance commercialization of microbial proteins. • The U.S.: Continued focus is on commercializing microbial protein-based foods. In 2025, Nature's Find (now Every) expanded the commercial availability of Fy protein-based foods to large retailers. The Every Company also continued its commercial partnerships to develop egg proteins. Continued commercial interest and investments in microbial protein productions by food retailers may incentivize the construction of larger production and fermentation facilities. • China: Also focused on the commercialization of microbial protein-based foods. In 2025, the Chinese National Health Commission announced a series of food safety regulations and expanded the review of foods of non-traditional safety to include microbial proteins. Additionally, the commission reviewed and approved several food additives. Other Food and Fermentation companies in China may facilitate the commercialization of microbial protein-based foods. • Germany: German developers integrated both venture capital and industrial partnerships. The Protein Brewery, in conjunction with German food companies, continued work on fermentation of protein ingredients in early 2025, and Formo, in 2024, having raised €61 million, expanded its animal-free dairy offering. Local industrial partnerships and collaborations play a pivotal role in developing and commercializing alternative protein sources in Europe. • India: The biotech and alternative protein sectors have benefitted from pro-industry fiscal policy and increasing investment. In February 2025, the Indian budget allocated $125 million to the National Manufacturing Mission for biotech and fermentation equipment. String Bio, in collaboration with researchers at the Institute of Stem Cell Biology and Institute of Integrative Biology, also advanced the microbial production of proteins in 2025. • Japan: Alternative proteins are manufactured using microorganisms and fermentation, which requires an advanced and integrated biological, food, and chemical industry. Some Japanese food and chemical companies are focusing on development and research of alternative proteins. In 2025, Ajinomoto focused on amino acids and fermentation. Features of the Global Microbial Protein Market Market Size Estimates: microbial protein market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions. Segmentation Analysis: microbial protein market size by protein type, application, and region in terms of value ($B). Regional Analysis: microbial protein market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different protein types, applications, and regions for the microbial protein market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the microbial protein market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model. If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more. This report answers following 11 key questions: Q.1. What are some of the most promising, high-growth opportunities for the microbial protein market by protein type (algae protein, mycoprotein, bacterial protein, and yeast protein), application (food & beverages, supplements, animal feed, industrial, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)? Q.2. Which segments will grow at a faster pace and why? Q.3. Which region will grow at a faster pace and why? Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market? Q.5. What are the business risks and competitive threats in this market? Q.6. What are the emerging trends in this market and the reasons behind them? Q.7. What are some of the changing demands of customers in the market? Q.8. What are the new developments in the market? Which companies are leading these developments? Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth? Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution? Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?